Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000247016 | SCV000316359 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Eurofins Ntd Llc |
RCV000247016 | SCV000331350 | benign | not specified | 2015-10-08 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000247016 | SCV000516256 | benign | not specified | 2016-03-03 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
ARUP Laboratories, |
RCV001812744 | SCV000603492 | benign | not provided | 2023-11-29 | criteria provided, single submitter | clinical testing | |
Pars Genome Lab | RCV001527582 | SCV001738679 | benign | Ellis-van Creveld syndrome | 2021-06-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001660369 | SCV001876209 | benign | Curry-Hall syndrome | 2021-07-30 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001527582 | SCV001876210 | benign | Ellis-van Creveld syndrome | 2021-07-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002058430 | SCV002326681 | benign | Ellis-van Creveld syndrome; Curry-Hall syndrome | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001812744 | SCV005297757 | benign | not provided | criteria provided, single submitter | not provided |